Section Arrow
NXL.NASDAQ
- Nexalin Technology
(Financial Status)
Quotes are at least 15-min delayed:2026/04/25 19:10 EDT
Regular Hours
Last
 0.4259
-0.0052 (-1.21%)
Day High 
0.4597 
Prev. Close
0.4311 
1-M High
0.509 
Volume 
234.35K 
Bid
0.4259
Ask
0.4589
Day Low
0.4176 
Open
0.426 
1-M Low
0.3302 
Market Cap 
8.87M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.45 
20-SMA 0.41 
50-SMA 0.43 
52-W High
52-W Low 0.3302 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.50/--
Enterprise Value
8.87M
Balance Sheet
Book Value Per Share
0.18
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
301.65K
Operating Revenue Per Share
0.03
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ITOCiTonic Holdings Ltd.0.374+0.0744+24.83%-- 
BSXBoston Scientific Corp62.07-3.62-5.51%33.94PE
ABTAbbott Laboratories91.13-1.35-1.46%24.75PE
EWEdwards Lifesciences Corp84.15+4.43+5.56%45.45PE
PACBPacific Biosciences of California1.56-0.01-0.64%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 orGen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.